Pioneering the future of brain-computer interfaces for the treatment of cognitive disorders
Nia’s mission is to transform treatment for the 27 million Americans living with memory loss through closed-loop brain stimulation, while generating neural insights that will drive the future of therapies for cognitive disorders.
Nia Therapeutics has received FDA Breakthrough Device Designation for its AI-guided brain implant designed to treat memory loss through targeted neurostimulation.
A precisely timed pulse to a brain area just behind the ear can help reduce memory deficits in patients suffering moderate to severe traumatic brain injuries.